StockNews.com began coverage on shares of Athersys (NASDAQ:ATHX – Free Report) in a report issued on Monday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock.
Athersys Stock Performance
Athersys has a one year low of $0.01 and a one year high of $1.99. The company has a market capitalization of $833,000.00, a P/E ratio of -0.01 and a beta of -0.90.
Athersys Company Profile
See Also
- Five stocks we like better than Athersys
- Investing in Commodities: What Are They? How to Invest in Them
- Analysts Predict New Highs for Cybersecurity Stock by Christmas
- Best Aerospace Stocks Investing
- Nuclear Power Reaches Critical Mass: Top Stocks to Watch Now
- Insider Buying Explained: What Investors Need to Know
- 2 Energy Stocks Surging on Billion-Dollar DOE Loan Commitments
Receive News & Ratings for Athersys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Athersys and related companies with MarketBeat.com's FREE daily email newsletter.